Generalao, Baby Girl .

HRN: 29-18-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/19/2026
06/25/2026
IV
50mg
Q24
NAMF PROM X 20hours
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: